Adrenomedullin refines mortality prediction by the BODE index in COPD: the "BODE-A" index
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID 3887537
Author(s) Stolz, Daiana; Kostikas, Kostantinos; Blasi, Francesco; Boersma, Wim; Milenkovic, Branislava; Lacoma, Alicia; Louis, Renaud; Aerts, Joachim G.; Welte, Tobias; Torres, Antoni; Rohde, Gernot G. U.; Boeck, Lucas; Rakic, Janko; Scherr, Andreas; Hertel, Sabine; Giersdorf, Sven; Tamm, Michael
Author(s) at UniBasel Boeck, Lucas
Year 2014
Title Adrenomedullin refines mortality prediction by the BODE index in COPD: the "BODE-A" index
Journal European Respiratory Journal
Volume 43
Number 2
Pages / Article-Number 397-408
Abstract The BODE (body mass index, airflow obstruction, dyspnoea, exercise capacity) index is well-validated for mortality prediction in chronic obstructive pulmonary disease (COPD). Concentrations of plasma pro-adrenomedullin, a surrogate for mature adrenomedullin, independently predicted 2-year mortality among inpatients with COPD exacerbation. We compared accuracy of initial pro-adrenomedullin level, BODE and BODE components, alone or combined, in predicting 1-year or 2-year all-cause mortality in a multicentre, multinational observational cohort with stable, moderate to very severe COPD. Pro-adrenomedullin was significantly associated (p<0.001) with 1-year mortality (4.7%) and 2-year mortality (7.8%) and comparably predictive to BODE regarding both (C statistics 0.691 versus 0.745 and 0.635 versus 0.679, respectively). Relative to using BODE alone, adding pro-adrenomedullin significantly improved 1-year and 2-year mortality prognostication (C statistics 0.750 and 0.818, respectively; both p<0.001). Pro-adrenomedullin plus BOD was more predictive than the original BODE including 6-min walk distance. In multivariable analysis, pro-adrenomedullin (likelihood ratio Chi-squared 13.0, p<0.001), body mass index (8.5, p=0.004) and 6-min walk distance (7.5, p=0.006) independently foretold 2-year survival, but modified Medical Research Council dyspnoea score (2.2, p=0.14) and forced expiratory volume in 1 s % predicted (0.3, p=0.60) did not. Pro-adrenomedullin plus BODE better predicts mortality in COPD patients than does BODE alone; pro-adrenomedullin may substitute for 6-min walk distance in BODE when 6-min walk testing is unavailable.
Publisher European Respiratory Society
ISSN/ISBN 0903-1936 ; 1399-3003
Full Text on edoc No
Digital Object Identifier DOI 10.1183/09031936.00058713
PubMed ID
Document type (ISI) Journal Article, Multicenter Study

MCSS v5.8 PRO. 0.621 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |